The Role of Immune Checkpoint Inhibitors in Cancer Therapy: Mechanism and Therapeutic Advances
Hengyi Chen(University of Alicante), Qingxiang Sun(University of Electronic Science and Technology of China), Lu Guo(University of Electronic Science and Technology of China), Hongling Yang(University of Electronic Science and Technology of China)
Cited by 23
Related Papers
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
|Blood|2012|300
Structural Basis for the Inhibition Mechanism of Human Cystathionine γ-Lyase, an Enzyme Responsible for the Production of H2S
|Journal of Biological Chemistry|2008|206
Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
|Proceedings of the National Academy of Sciences|2013|196
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
|Leukemia|2012|193
Nuclear transport proteins: structure, function and disease relevance
|Signal Transduction and Targeted Therapy|2023|178